Mode
Text Size
Log in / Sign up
N/A Completed N=14 Randomized Single-blind Basic Science

Cognitive Recovery After Electroconvulsive Therapy and General Anesthesia

Depression · Delirium · Seizures · Cognitive Disorders
Source: ClinicalTrials.gov NCT02761330 ↗
Enrolled (actual)
14
Serious AEs
0.0%
Results posted
Jun 2021
Primary outcomePrimary: Change in Cognitive Function During Recovery: Rate of Recovery — 3.5; 6.3; 24.7; 9.7 inverse hours — p=0.016

Summary

This study is geared toward characterizing the recovery of brain activity and cognitive function following treatments of electroconvulsive therapy and ketamine general anesthesia.

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Cognitive Function During Recovery: Rate of Recovery
3.5; 6.3; 24.7; 9.7; 3.0; 2.9 0.016 sig
PRIMARY
Change in Cognitive Function During Recovery: Initial Decrement
0.4; 3.5; 6.8; 2.4; 5.1; 3.1 0.016 sig
SECONDARY
Delirium Incidence and Severity
1; 0; 0; 20; 23; 23
SECONDARY
Suicidality
0.077; 0.077
SECONDARY
ECT Seizure Duration
SECONDARY
ECT Electrical Dose
32.5
SECONDARY
Subjective Assessment of Whether ECT Was Performed, Determined by Asking the Patient.
18; 18; 6
SECONDARY
Change in Mood Assessed Using the Mood Self-Assessment Manikin
-0.266
SECONDARY
Average Change in Mood Based on the Depression PROMIS-CAT
-0.5108
SECONDARY
Change in Delta Band (0.5-4 Hz) Relative Power in the Scale EEG During Recovery
-0.064; -0.111; -0.038 0.301
SECONDARY
Change in Theta Band (4-8 Hz) Relative Power in the Scalp EEG During Recovery
-0.008; -0.015; 0.015 0.910
SECONDARY
Change in Alpha Band (8-13 Hz) Power in the Scalp EEG During Recovery
0.016; 0.053; 0.006 0.164
SECONDARY
Change in Beta Band (13-20 Hz) Relative Power in the Scalp EEG During Recovery
-0.001; -0.004; -0.008 0.910
SECONDARY
Change in Anterior-Posterior Functional Connectivity in the Scalp During Recovery
-0.014; -0.002; -0.004 0.129
SECONDARY
Change in Anterior-Posterior Phase-lag in the Scalp EEG During Recovery
-0.001; -0.049; -0.017 1.000
SECONDARY
Change in EEG Entropy in the Scalp EEG During Recovery
-0.018; -0.003; -0.006 0.008 sig

Eligibility Criteria

Inclusion Criteria

  • Treatment resistant depression requiring outpatient ECT
  • Planned right unilateral ECT stimulation
  • English speaking
  • Able to provide written informed consent

Exclusion Criteria

  • Known brain lesion or neurological illness that causes cognitive impairment
  • Schizophrenia
  • Schizoaffective disorder
  • Blindness or deafness or motor impediments that may impair performance for cognitive testing battery
  • Inadequate ECT seizure duration with etomidate
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02761330). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search